We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 46

USPTO Says Overlapping Range In Prior Art Insufficient to Invalidate Method of Treatment Patent
  • Dechert LLP
  • USA
  • April 13 2018

Pharmaceutical patents frequently claim treatment methods that utilize a range of amounts or concentrations for the active ingredient or excipients


Federal Circuit Finds "Consisting Of" Requires Reversing Infringement Of Shire Lialda Patent
  • Foley & Lardner LLP
  • USA
  • February 14 2017

The Federal Circuit focused on the “consisting of” language in the claims at issue when it reversed the district court’s finding that Watson’s ANDA


Highlights on the draft rules of drug registration
  • King & Wood Mallesons
  • China
  • August 1 2016

On July 25, 2016, the China Food and Drug Administration ("CFDA") published the Administrative Provisions for Drug Registration (Revision) (the


Draft Guideline on the sterilisation of the medicinal product, active substance, excipient and primary container
  • Hogan Lovells
  • European Union
  • April 21 2016

On 11 April 2016 a draft Guideline on the sterilisation of the medicinal product, active substance, excipient and primary container (“the Draft


Formulation patent found not to be infringed as a redacted excipient was not a “pentahydric or hexahydric alcohol”
  • Borden Ladner Gervais LLP
  • Canada
  • April 22 2015

Apotex has successfully alleged that Teva’s patent to “Stable Compositions Containing Rasagiline” will not be infringed by Apotex’s use of a


Federal court considers "pharmaceutical substance" and upholds extension of patent term granted to Mundipharma Pty Ltd
  • Davies Collison Cave
  • Australia
  • July 15 2013

In a recent judgment handed down by the Federal Court, Justice Rares found that a pharmaceutical formulation containing the known active agent


Interim measures awarded against European medicines agency
  • Bird & Bird
  • European Union
  • June 5 2013

Article 4(2) of EU Regulation 10492001, which governs freedom of information as to documents filed with EU agencies, requires that institutions such


Entry into force of new regulations for pharmaceutical excipients
  • CMS
  • China
  • January 29 2013

On 1 August 2012, as a result of the toxic capsule scandal, the State Food and Drug Administration ("SFDA") issued Provisions on Strengthening the


Entry into force of new regulations for pharmaceutical excipients old wine in a new bottle?
  • CMS
  • China
  • January 23 2013

On 1 August 2012, as a result of the toxic capsule scandal, the State Food and Drug Administration ("SFDA") issued Provisions on Strengthening the


Clinical trial invalidates European patent
  • Foley & Lardner LLP
  • European Union
  • December 13 2011

Pharmaceutical inventions usually require human clinical testing in order to obtain regulatory approval to market the new product.